secwatch.observer — SEC 8-K summary
======================================

Issuer:     Incannex Healthcare Inc. (IXHL)
CIK:        0001873875
Form:       8-K
Filed at:   2025-06-24T23:59:59+00:00
Accession:  0001213900-25-056901
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Incannex appoints Dr. Kirsch to OSA board; Phase 2 data due July 2025
---------------------------------------------------------------------

- Appointed Douglas B. Kirsch, M.D., FAAN, FAASM to IHL-42X Obstructive Sleep Apnea Clinical Advisory Board.
- Dr. Kirsch is Medical Director of Atrium Health Sleep Medicine and former President of the American Academy of Sleep Medicine.
- Company expects to report topline Phase 2 data from the U.S. RePOSA study in July 2025.
- Phase 3 initiation for IHL-42X targeted for later in 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873875/000121390025056901/0001213900-25-056901-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873875/000121390025056901/ea0246656-8k_incannex.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-056901

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer